BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 33094396)

  • 1. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
    Hafez EA; Hassan SAE; Teama MAM; Badr FM
    Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?
    Ugolini-Lopes MR; Gavinier SS; Leon E; Viana VT; Borba EF; Bonfá E
    Clin Rheumatol; 2019 Oct; 38(10):2777-2783. PubMed ID: 31154554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.
    Calich AL; Borba EF; Ugolini-Lopes MR; da Rocha LF; Bonfá E; Fuller R
    Clin Rheumatol; 2018 May; 37(5):1223-1228. PubMed ID: 29353328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Ugarte-Gil MF; Gamboa-Cárdenas RV; Zevallos F; Cucho-Venegas JM; Alfaro-Lozano JL; Medina M; Rodriguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos RA
    Clin Rheumatol; 2017 Apr; 36(4):845-852. PubMed ID: 28101832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
    Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
    Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction].
    Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ
    Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis?
    Gianfreda D; Quaglini S; Frontini G; Raffiotta F; Messa P; Moroni G
    J Autoimmun; 2017 Nov; 84():46-54. PubMed ID: 28647487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
    Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
    Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus.
    Kandane-Rathnayake R; Kent JR; Louthrenoo W; Luo SF; Wu YJ; Lateef A; Golder V; Sockalingam S; Navarra SA; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Lau CS; Hoi A; Nikpour M; Morand E
    Lupus; 2019 Dec; 28(14):1669-1677. PubMed ID: 31718467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Outcomes and Risk Factors for Nephritis (Flare/
    Buyon JP; Kim MY; Guerra MM; Lu S; Reeves E; Petri M; Laskin CA; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Sawitzke A; Merrill JT; Stephenson MD; Cohn E; Salmon JE
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):940-946. PubMed ID: 28400421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study.
    Gamal DM; Badr FM; Taha SIAEF; Moustafa NM; Teama MAEM
    Rheumatol Int; 2023 Feb; 43(2):323-333. PubMed ID: 36205758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.